Prague Med. Rep. 2015, 116, 253-267
https://doi.org/10.14712/23362936.2015.65
Pancreatic Cancer Diagnostics and Treatment – Current State
Crossref Cited-by Linking
- Aslam Murtaza, Rajbdad Fozia, Azmat Shoaib, Li Zheng, Boudreaux J. Philip, Thiagarajan Ramcharan, Yao Shaomian, Xu Jian: A novel method for detection of pancreatic Ductal Adenocarcinoma using explainable machine learning. Computer Methods and Programs in Biomedicine 2024, 245, 108019. <https://doi.org/10.1016/j.cmpb.2024.108019>
- Prinz Christian, Fehring Leonard, Frese Robin: MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions. Cells 2022, 11, 2374. <https://doi.org/10.3390/cells11152374>
- Wang Chu-An, Li Chien-Feng, Huang Rho-Chi, Li Yo-Hua, Liou Jing-Ping, Tsai Shaw-Jenq: Suppression of Extracellular Vesicle VEGF-C–mediated Lymphangiogenesis and Pancreatic Cancer Early Dissemination By a Selective HDAC1/2 Inhibitor. Molecular Cancer Therapeutics 2021, 20, 1550. <https://doi.org/10.1158/1535-7163.MCT-20-0963>
- Bettaieb Louay, Brulé Maxime, Chomy Axel, Diedro Mel, Fruit Malory, Happernegg Eloise, Heni Leila, Horochowska Anaïs, Housseini Mahya, Klouyovo Kekely, Laratte Agathe, Leroy Alice, Lewandowski Paul, Louvieaux Joséphine, Moitié Amélie, Tellier Rémi, Titah Sofia, Vanauberg Dimitri, Woesteland Flavie, Prevarskaya Natalia, Lehen’kyi V’yacheslav: Ca2+ Signaling and Its Potential Targeting in Pancreatic Ductal Carcinoma. Cancers 2021, 13, 3085. <https://doi.org/10.3390/cancers13123085>
- Cai Q., Mao Y., Yang Q., Wen H., Lv Y., Zhang R.: Are left ventricular muscle area and radiation attenuation associated with overall survival in advanced pancreatic cancer patients treated with chemotherapy?. Clinical Radiology 2020, 75, 238.e1. <https://doi.org/10.1016/j.crad.2019.11.003>
- Rong Dailin, Mao Yize, Hu Wanming, Xu Shuhang, Wang Jun, He Haoqiang, Li Shengping, Zhang Rong: Intravoxel incoherent motion magnetic resonance imaging for differentiating metastatic and non-metastatic lymph nodes in pancreatic ductal adenocarcinoma. Eur Radiol 2018, 28, 2781. <https://doi.org/10.1007/s00330-017-5259-0>
- Chen Linyan, Zhang Yi, Cheng Yuan, Zhang Dan, Zhu Sha, Ma Xuelei: Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis. Gene 2018, 679, 328. <https://doi.org/10.1016/j.gene.2018.09.029>
- Chattaragada M S, Riganti C, Sassoe M, Principe M, Santamorena M M, Roux C, Curcio C, Evangelista A, Allavena P, Salvia R, Rusev B, Scarpa A, Cappello P, Novelli F: FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis. Oncogene 2018, 37, 697. <https://doi.org/10.1038/onc.2017.358>
- Vainer Noomi, Dehlendorff Christian, Johansen Julia S.: Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer. Oncotarget 2018, 9, 29820. <https://doi.org/10.18632/oncotarget.25661>
- Qian Cui‑Juan, Qi Yong‑Xiao, Zhong Sheng, Zeng Ju‑Ping, Chen Xiao‑Ying, Yao Jun: Mitogen‑activated protein kinase inhibition enhances the antitumor effects of sporamin in human pancreatic cancer cells. Oncol Lett 2018. <https://doi.org/10.3892/ol.2018.8746>
- Berry William, Algar Elizabeth, Kumar Beena, Desmond Christopher, Swan Michael, Jenkins Brendan J., Croagh Daniel: Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors. Int. J. Cancer 2017, 140, 2331. <https://doi.org/10.1002/ijc.30648>
- He Mu, Qiao Zhixin, Wang Yanbing, Kuai Qiyuan, Li Changlan, Wang Yu, Jiang Xingwei, Wang Xuanlin, Li Weijing, He Min, Ren Suping, Yu Qun, Tan Ming: Chidamide Inhibits Aerobic Metabolism to Induce Pancreatic Cancer Cell Growth Arrest by Promoting Mcl-1 Degradation. PLoS ONE 2016, 11, e0166896. <https://doi.org/10.1371/journal.pone.0166896>
